COVID-19 危重症患者的静脉-动脉-静脉体外膜肺氧合。
Veno-Arterial-Venous Extracorporeal Membrane Oxygenation in a Critically Ill Patient with Coronavirus Disease 2019.
机构信息
Department of Thoracic and Cardiovascular Surgery, College of Medicine, Gyeongsang National University, Gyeongsang National University Changwon Hospital, Changwon 51472, Korea.
Department of Internal Medicine, College of Medicine, Gyeongsang National University, Gyeongsang National University Changwon Hospital, Changwon 51472, Korea.
出版信息
Medicina (Kaunas). 2020 Sep 30;56(10):510. doi: 10.3390/medicina56100510.
Patients with cardiopulmonary failure may not be fully supported with typical configurations of extracorporeal membrane oxygenation (ECMO), either veno-arterial (VA) or veno-venous (VV). Veno-arterial-venous (VAV)-ECMO is a technique used to support the cardiopulmonary systems during periods of inadequate gas exchange and perfusion. In the severe case of coronavirus disease 2019 (COVID-19), which simultaneously affects the heart and lung, VAV-ECMO may improve a patient's recovery potential. We report the case of a 72-year-old woman with acute respiratory distress syndrome and circulatory failure following COVID-19, who was treated with VAV-ECMO.
心肺衰竭的患者可能无法通过典型的体外膜肺氧合（ECMO）配置（即静脉-动脉[VA]或静脉-静脉[VV]）得到充分支持。静脉-动脉-静脉（VAV）-ECMO 是一种用于在气体交换和灌注不足期间支持心肺系统的技术。在同时影响心脏和肺部的 2019 年冠状病毒病（COVID-19）的严重情况下，VAV-ECMO 可能会提高患者的恢复潜力。我们报告了一例 72 岁女性 COVID-19 后急性呼吸窘迫综合征和循环衰竭的病例，该患者接受了 VAV-ECMO 治疗。
Zotero 插件